Great Point Partners, LLC 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-17 4:00 pm Purchase | 2025-12-10 | 13G | Vor Biopharma Inc. VOR | Great Point Partners, LLC | 1,234,486 5.630% | 1,234,486 (New Position) | Filing |